Flexitab™ Tablets

Safer to Use™ Breakable Extended Release Tablets for Precise Titration

Altus leverages Flexitab, a proprietary drug delivery technology, in the formulation of value-added medicines which are co-developed and commercialized with partners around the globe.

Pharmaceutical formulation, research and development

We leverage our Flexitab drug development technology to offer drug development services, working with co-development partners to conduct pharmaceutical research and development to create customized pharmaceutical formulations based on market needs

Platform

High and low drug load, breakable extended-release tablets that are impervious to alcohol and avoid the dangers of dose dumping when split. Splitting Flexitab tablets into multiple segments generates a range of dose-proportional extended-release tablets.

Value Drivers: Differentiated Value-Added Drugs

Flexitab tablet technology provides safe, precise, and flexible dosing for titration sensitive and narrow therapeutic index drugs generating new low strength options for drug-naïve patients and additional intermediate strengths to meet individual patient needs. Flexitab provides precise control of the efficacy/side-effect balance keeping patients on the lowest dose drug they need for the whole time they need it.

Exclusivity

The new labelling that Flexitab products obtain, describing the safe breakability of the tablets, prevents interchangeability (substitution) with non-breakable extended products. Flexitab provides clinically and medically relevant differentiation for existing immediate release and extended-release products in addition to the convenience of an extended release product.

Cost Effectiveness

Pharmaceutical research and development can be costly. Many Flexitab products can be approved on the basis of pharmacokinetic studies alone. Flexitab also avoids the costs of multiple tablet manufacturing in the development of pharmaceutical preparations through a simple direct compression process.

Patent Protection

All Flexitab tablets fall under Altus global patent umbrella which provides protection to 2038.

Learn more about Altus Value Added Medicines

Contact Us